Revance Therapeutics revance.com


Revance Therapeutics is a privately held specialty biopharmaceutical company which develops next generation products in dermatology and therapeutic medicine. Revance has developed a platform technology, TransMTS that enables local, targeted delivery of botulinum toxin and other potent macromolecules across skin without patches, needles or other invasive procedures.

Revance Therapeutics is a privately held specialty biopharmaceutical company which develops next generation products in dermatology and therapeutic medicine. Revance has developed a platform technology, TransMTS that enables local, targeted delivery ...Show all

Company (IPO / Went public)

Phone: 510-742-3400

Fax:

7555 Gateway Blvd

Newark, 94560
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Revance Therapeutics $285.8M Feb 6, 2014
Barrier Therapeutics $156.2M Aug 20, 2008
Biofisica $9.3M Apr 21, 2008
See all 32 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Revance Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 15 investors

Competitors

Company Status Description Investors
See all 32 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Injectable botulinum toxin formulations Dec 28, 2009 May 01, 2018 Patent
Extended length botulinum toxin formulation for human or mammalian use Jun 29, 2015 Apr 24, 2018 Patent
Topical ocular preparation of botulinum toxin for use in ocular surface disease Jul 20, 2015 Feb 27, 2018 Patent
Methods and systems for purifying non-complexed botulinum neurotoxin Jul 10, 2015 Oct 18, 2016 Patent
Albumin-free botulinum toxin formulations Jun 25, 2010 May 17, 2016 Patent
See all 38 patents